Trial intelligence / Profile preview

Bioequivalence of Levonorgestrel Tablet 0.75 mg vs POSTINOR in healthy Thai volunteers (fasting)

TCTR20170213001Phase 1Not yet recruiting

Sponsor
Bio-innova
Start
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of avatrombopag in unintended pregnancy (2 arms), sponsored by Bio-innova. Planned start Feb 2017; status: not yet recruiting.

02

Drugs

avatrombopag
03

Conditions

unintended pregnancy

Beyond the preview

Go deeper on TCTR20170213001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20170213001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call